RealFeedApp beta

Seawolf Therapeutics raised $100 million

Seawolf Therapeutics received $100 million to support its research into DNA-based therapies. The deal includes partners like Versant Ventures, Eli Lilly, CRISPR Therapeutics, and Sanofi, which could pay up to $1.2 billion in milestone payments.

Field
gene therapy
What they did
Seawolf Therapeutics received $100 million to develop DNA-based therapies, including a partnership with Sanofi.
Why it matters
According to the agreement, the company could receive up to $1.2 billion for meeting milestones and receiving royalties from future products.
#dna therapeutics#seawolf therapeutics#versant ventures#sanofi#seed funding

Read the original →